Magnetic Nanoparticle Sterility Testing for Fast Microbe Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current sterility testing methods for biopharmaceuticals are time-consuming, labor-intensive, and prone to false positives/negatives, posing a clinical risk due to delayed detection of microbial contaminants, especially in products with short shelf lives.
Innovation Solution
A rapid sterility testing method using magnetic particles coated with proteins to bind to microorganisms, combined with a biochip and automated imaging equipment, allows for rapid separation and detection of microbial metabolites through fluorescence or color changes in a biochip system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If the membrane filtration method is used for sterility testing, then the test can detect microorganisms through turbidity measurement, but the testing time requires about two weeks which is too long for biopharmaceuticals with short shelf lives
Solution Approach 1:
The invention extracts and isolates microorganisms from the complex biopharmaceutical matrix using magnetic particles coated with specific proteins. This separation step removes interfering substances and concentrates microorganisms, enabling rapid detection without the lengthy two-week incubation period required by conventional methods.
Solution Approach 2:
The invention introduces magnetic particles coated with microorganism-binding proteins as an intermediary between the sample and detection system. These particles specifically capture microorganisms while allowing rapid separation and detection, bridging the gap between complex biopharmaceutical samples and simple detection methods.
2Measurement precision
If conventional sterility testing methods are used, then microorganism detection can be performed, but the process is labor-intensive and requires standardized manual operations
Solution Approach 1:
The invention enables the system to perform separation and detection automatically without manual intervention. Magnetic particles self-assemble around microorganisms, and the magnetic separation process occurs automatically, eliminating the need for labor-intensive manual filtration and observation steps.
Solution Approach 2:
The invention replaces manual mechanical filtration operations with magnetic field-based separation. Instead of physically handling filters and observing turbidity changes manually, the system uses magnetic fields to separate and concentrate microorganisms, which are then detected through automated imaging or spectroscopic methods.
3Loss of time
If rapid detection methods like solid phase cytometry or PCR are used, then testing time can be reduced to approximately three hours, but these methods have high false positive and false negative rates and are difficult to apply universally
Solution Approach 1:
The invention creates a universal detection platform that can identify various types of microorganisms (bacteria, fungi, mycoplasma) across different biopharmaceutical products using the same magnetic particle-based approach. The coated particles bind to common components of microbial cells, making the method broadly applicable while maintaining high accuracy.
Solution Approach 2:
The invention uses composite magnetic particles with specific surface coatings that combine the magnetic separation capability with microorganism-specific binding properties. This composite structure enables both rapid separation and specific recognition of microorganisms, reducing false positives and negatives while maintaining universality across different microbial types.
4Loss of time
If metabolite detection methods are used to detect microorganisms, then detection can be performed without cultivation, but biopharmaceutical components and microorganisms cannot be effectively separated leading to interference and false positives
Solution Approach 1:
The invention extracts microorganisms from the biopharmaceutical matrix using magnetic particles before detection. This physical separation removes interfering biopharmaceutical components that would otherwise produce false positive signals in metabolite-based detection methods, enabling specific and rapid detection.
Solution Approach 2:
The magnetic particles serve as an intermediary that selectively binds to microorganisms while leaving biopharmaceutical components in solution. This intermediary step allows subsequent detection methods to specifically measure microbial metabolites without interference from pharmaceutical components.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly reduces sterility test time from 14 days to 24 hours, enhances detection sensitivity, and improves analytical specificity, enabling real-time monitoring and reducing logistical and labor costs.
Implementation Method 1
mixing magnetic particles with a test subject material to bind a target analyte to the magnetic particles; separating the magnetic particles from the test subject material
Implementation Method 2
determining whether the target analyte is present in the sample by comparing fluorescence or color of images of the sample and the control
Implementation Method 3
determining whether the target analyte is present in the sample by comparing fluorescence or color of images of the sample and the control
Data Source
Figure 1(a)~1(b)
Figure 2(a)~2(c)
Figure 3(a)~3(b)
AI summary
This invention relates to an integrated system and methodology for drastically reducing the time required for sterility testing used to verify safety during the manufacturing process of biopharmaceuticals. More specifically, the invention provides a rapid sterility test method and a rapid sterility test platform for demonstrating the safety of biopharmaceuticals, comprising magnetic nanoparticles coated with a protein capable of binding to microorganisms, a biochip specialized for nanoparticle-based analysis, an automated imaging device and analysis software, and the procedures and methods for performing rapid sterility testing.